Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

Go back to Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
(NASDAQ: MNPR) Delayed: 107.72 -3.16 (2.85%)
Previous Close $110.88    52 Week High
Open $111.98    52 Week Low
Day High $113.46    P/E N/A 
Day Low $105.42    EPS
Volume 176,420